The American Diabetes Association (ADA) is proud to publish the 2018 edition of the Standards of Medical Care in Diabetes, the global standard for diabetes care. Produced annually by the ADA since 1989, the Standards of Care is the primary resource to ensure personalized diabetes care focused on improving patient outcomes and quality of life.
Notable new recommendations
• The use of certain antihyperglycemic agents to reduce the risk of cardiovascular events and/or death in adults with type 2 diabetes and cardiovascular disease. The discussion of antihyperglycemic drugs with risks for hypoglycemia
• Routine screening for overweight youth with one or more additional risk factors
• At-home blood pressure monitoring for patients with diagnosed hypertension to be used more
• Patient-centered care that considers limitations of the A1C test for diagnosis in some scenarios and provides alternative strategies
• Specialized care for older adults and during pregnancy Use of new diabetes technology and tools to help improve patient outcomes
Also new in 2018, the Standards of Care will be updated throughout the year with necessary annotations if new evidence or regulatory changes merit immediate incorporation.
This will ensure that the Standards of Care provide the most up-to-date guidance on diabetes care, general treatment goals and tools to evaluate the quality of care.
Frewware, inget lösenord, kapitel för kapitel att ladda ner, totalt 157 sidor, om alla kapitel
The 2018 Standards of Medical Care in Diabetes Care includes all of ADA's current clinical practice recommendations and is intended to provide clinicians, patients, researchers, payers, and others with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care.
The recommendations are based on an extensive review of the clinical diabetes literature, supplemented with input from ADA staff and the medical community at large. The Standards of Medical Care in Diabetes is updated annually, or more frequently online if new evidence or regulatory changes merit immediate incorporation, and is published in Diabetes Care
Nyhetsinfo
www red DiabetologNytt